GlobeNewswire·Nov 3, 2025, 4:15 PM ET

NANOBIOTIX to Participate in Investor Conferences the Week of November 10th

Nanobiotix announced that its management will participate in fireside chats at three upcoming conferences in November 2025.
Bart van Rhijn, Chief Financial & Business Officer, will present at the UBS Global Healthcare Conference on November 10, 2025, at 5pm ET in Palm Beach Gardens, FL.
Laurent Levy, Chief Executive Officer, will present at Guggenheim's Annual Healthcare Innovation Conference on November 10, 2025, at 4:30pm ET in Boston, MA, with a webcast link available.
Both Laurent Levy & Bart van Rhijn will present at the Stifel Healthcare Conference on November 13, 2025, at 8am ET in New York, NY.
Recorded fireside chats will be webcast live from the Investors section of the Nanobiotix website, with replays available following the events.
Nanobiotix is a late-stage clinical biotechnology company headquartered in Paris, France, with a subsidiary in Cambridge, Massachusetts, & listed on Euronext Paris & Nasdaq Global Select Market.
The company holds more than 25 patent families associated with three nanotechnology platforms targeting oncology, bioavailability & biodistribution, & disorders of the central nervous system.
Contact information for Communications, Investor Relations, & Media Relations departments is provided for further inquiries.